Literature DB >> 26242008

In Reply.

A Vogel.   

Abstract

Mesh：

Year:  2015        PMID： 26242008      PMCID： PMC4496481          DOI： 10.3238/arztebl.2015.0373

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.

Authors:  David Malka; Pascale Cervera; Stéphanie Foulon; Tanja Trarbach; Christelle de la Fouchardière; Eveline Boucher; Laetitia Fartoux; Sandrine Faivre; Jean-Frédéric Blanc; Frédéric Viret; Eric Assenat; Thomas Seufferlein; Thomas Herrmann; Julien Grenier; Pascal Hammel; Matthias Dollinger; Thierry André; Philipp Hahn; Volker Heinemann; Vanessa Rousseau; Michel Ducreux; Jean-Pierre Pignon; Dominique Wendum; Olivier Rosmorduc; Tim F Greten
Journal:  Lancet Oncol       Date:  2014-05-19       Impact factor: 41.316

Review 2.  The diagnosis and treatment of cholangiocarcinoma.

Authors:  Arndt Vogel; Henning Wege; Karel Caca; Björn Nashan; Ulf Neumann
Journal:  Dtsch Arztebl Int       Date:  2014-10-31       Impact factor: 5.594

Review 3.  Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Joseph J Zechlinski; William S Rilling
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

4.  Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

Authors:  Samdeep Mouli; Khairuddin Memon; Talia Baker; Al B Benson; Mary F Mulcahy; Ramona Gupta; Robert K Ryu; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2013-04-19       Impact factor: 3.464
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.